These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11306716)

  • 21. 11beta-hydroxyprogesterone acts as a mineralocorticoid agonist in stimulating Na+ absorption in mammalian principal cortical collecting duct cells.
    Rafestin-Oblin ME; Fagart J; Souque A; Seguin C; Bens M; Vandewalle A
    Mol Pharmacol; 2002 Dec; 62(6):1306-13. PubMed ID: 12435797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The mineralocorticoid activity of progesterone derivatives depends on the nature of the C18 substituent.
    Souque A; Fagart J; Couette B; Davioud E; Sobrio F; Marquet A; Rafestin-Oblin ME
    Endocrinology; 1995 Dec; 136(12):5651-8. PubMed ID: 7588320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aldosterone antagonists. 2. New 7 alpha-(acetylthio)-15,16-methylene spirolactones.
    Nickisch K; Bittler D; Laurent H; Losert W; Casals-Stenzel J; Nishino Y; Schillinger E; Wiechert R
    J Med Chem; 1987 Aug; 30(8):1403-9. PubMed ID: 3612688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Docking and CoMSIA studies on steroids and non-steroidal chemicals as androgen receptor ligands.
    Wang X; Li X; Shi W; Wei S; Giesy JP; Yu H; Wang Y
    Ecotoxicol Environ Saf; 2013 Mar; 89():143-9. PubMed ID: 23260236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay.
    Ozers MS; Marks BD; Gowda K; Kupcho KR; Ervin KM; De Rosier T; Qadir N; Eliason HC; Riddle SM; Shekhani MS
    Biochemistry; 2007 Jan; 46(3):683-95. PubMed ID: 17223690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human expanded polyglutamine androgen receptor mutants in neurodegeneration as a novel ligand target.
    Furutani T; Takeyama K; Tanabe M; Koutoku H; Ito S; Taniguchi N; Suzuki E; Kudoh M; Shibasaki M; Shikama H; Kato S
    J Pharmacol Exp Ther; 2005 Nov; 315(2):545-52. PubMed ID: 16079302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stabilization of androgen receptor protein is induced by agonist, not by antagonists.
    Furutani T; Watanabe T; Tanimoto K; Hashimoto T; Koutoku H; Kudoh M; Shimizu Y; Kato S; Shikama H
    Biochem Biophys Res Commun; 2002 Jun; 294(4):779-84. PubMed ID: 12061774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgen receptor mutations causing human androgen insensitivity syndromes show a key role of residue M807 in Helix 8-Helix 10 interactions and in receptor ligand-binding domain stability.
    Ong YC; Kolatkar PR; Yong EL
    Mol Hum Reprod; 2002 Feb; 8(2):101-8. PubMed ID: 11818512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The synthetic androgen methyltrienolone (r1881) acts as a potent antagonist of the mineralocorticoid receptor.
    Takeda AN; Pinon GM; Bens M; Fagart J; Rafestin-Oblin ME; Vandewalle A
    Mol Pharmacol; 2007 Feb; 71(2):473-82. PubMed ID: 17105867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of steroid ligands able to inactivate the mineralocorticoid receptor harboring the S810L mutation responsible for a severe form of hypertension.
    Pinon GM; Fagart J; Souque A; Auzou G; Vandewalle A; Rafestin-Oblin ME
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):181-8. PubMed ID: 15134816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone.
    Culig Z; Hobisch A; Cronauer MV; Cato AC; Hittmair A; Radmayr C; Eberle J; Bartsch G; Klocker H
    Mol Endocrinol; 1993 Dec; 7(12):1541-50. PubMed ID: 8145761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The amino terminus of the human AR is target for corepressor action and antihormone agonism.
    Dotzlaw H; Moehren U; Mink S; Cato AC; Iñiguez Lluhí JA; Baniahmad A
    Mol Endocrinol; 2002 Apr; 16(4):661-73. PubMed ID: 11923464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C11-hydroxy and C11-oxo C
    Gent R; Van Rooyen D; Atkin SL; Swart AC
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanistic aspects of mineralocorticoid receptor activation.
    Hellal-Levy C; Fagart J; Souque A; Rafestin-Oblin ME
    Kidney Int; 2000 Apr; 57(4):1250-5. PubMed ID: 10760050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homology modelling of the ligand binding domain of mineralocorticoid receptor: close structural kinship with glucocorticoid receptor ligand binding domain and their similar binding mode with DOC (de-oxy corticosterone).
    Dey R; Roychowdhury P
    J Biomol Struct Dyn; 2002 Aug; 20(1):21-9. PubMed ID: 12144349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanisms.
    Hultman ML; Krasnoperova NV; Li S; Du S; Xia C; Dietz JD; Lala DS; Welsch DJ; Hu X
    Mol Endocrinol; 2005 Jun; 19(6):1460-73. PubMed ID: 15761029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific region in hormone binding domain is essential for hormone binding and trans-activation by human androgen receptor.
    Govindan MV
    Mol Endocrinol; 1990 Mar; 4(3):417-27. PubMed ID: 2342476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Switching androgen receptor antagonists to agonists by modifying C-ring substituents on piperidino[3,2-g]quinolinone.
    Zhi L; Tegley CM; Marschke KB; Jones TK
    Bioorg Med Chem Lett; 1999 Apr; 9(7):1009-12. PubMed ID: 10230629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of structure-activity relationship on 17-spirolactone derivatives: the electronic-topological approach.
    Kandemirli F; Tokay N; Shvets NM; Dimoglo AS
    Farmaco; 2002 Jul; 57(7):601-7. PubMed ID: 12164222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional and posttranscriptional regulation of human androgen receptor expression by androgen.
    Wolf DA; Herzinger T; Hermeking H; Blaschke D; Hörz W
    Mol Endocrinol; 1993 Jul; 7(7):924-36. PubMed ID: 8413317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.